原发性肾病综合征与ESKD、心血管事件及死亡风险:Kaiser Permanente肾病综合征研究
该研究在Kaiser Permanente Northern California系统内确认907例成人原发性肾病综合征患者(FSGS 40%、膜性肾病40%、微小病变20%),并与1:100时间匹配的无糖尿病、肾病综合征或蛋白尿的成人对照比较。结果显示患者ESKD、急性冠脉综合征、心衰、缺血性卒中、静脉血栓栓塞及死亡风险均显著升高,且ESKD风险因病因不同而异。
要点
- 成人原发性肾病综合征患者ESKD风险显著升高(aHR 19.63)。
- 心血管事件(ACS、心衰、卒中、VTE)及死亡风险亦显著增加。
- FSGS和膜性肾病的ESKD风险显著高于推测的微小病变。
核心结论
- 成人原发性肾病综合征患者调整后ESKD、心血管结局及死亡风险均更高。
- ESKD风险因基础病因不同而存在显著差异。
研究设计与样本
- 在Kaiser Permanente Northern California整合医疗系统内识别1996-2012年间有肾病范围蛋白尿或诊断为肾病综合征的成人。
- 肾脏科医生审查病历确认原发性肾病综合征并判定病因,最终确认907例患者(655例确诊,252例推测)。
- 设置1:100时间匹配的对照队列(无糖尿病、肾病综合征或蛋白尿的成人),随访至2014年,采用多变量Cox回归比较结局。
主要发现
- 与对照组相比,原发性肾病综合征患者ESKD调整风险比(aHR)为19.63(95%CI 12.76-30.20)。
- 急性冠脉综合征aHR 2.58(95%CI 1.89-3.52),心衰aHR 3.01(95%CI 2.16-4.19),缺血性卒中aHR 1.80(95%CI 1.06-3.05)。
- 静脉血栓栓塞aHR 2.56(95%CI 1.35-4.85),死亡aHR 1.34(95%CI 1.09-1.64)。
- FSGS和膜性肾病的ESKD超额风险显著高于推测的微小病变;三种病因在心血管结局和死亡方面无显著差异。
临床怎么用
- 对成人原发性肾病综合征患者应加强ESKD及心血管事件的监测与风险管理。
- 不同病因(如FSGS、膜性肾病)的ESKD风险存在差异,需个体化评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little population-based data exist about adults with primary nephrotic syndrome. METHODS: To evaluate kidney, cardiovascular, and mortality outcomes in adults with primary nephrotic syndrome, we identified adults within an integrated health care delivery system (Kaiser Permanente Northern California) with nephrotic-range proteinuria or diagnosed nephrotic syndrome between 1996 and 2012. Nephrologists reviewed medical records for clinical presentation, laboratory findings, and biopsy results to confirm primary nephrotic syndrome and assigned etiology. We identified a 1:100 time-matched cohort of adults without diabetes, diagnosed nephrotic syndrome, or proteinuria as controls to compare rates of ESKD, cardiovascular outcomes, and death through 2014, using multivariable Cox regression. RESULTS: We confirmed 907 patients with primary nephrotic syndrome (655 definite and 252 presumed patients with FSGS [40%], membranous nephropathy [40%], and minimal change disease [20%]). Mean age was 49 years; 43% were women. Adults with primary nephrotic syndrome had higher adjusted rates of ESKD (adjusted hazard ratio [aHR], 19.63; 95% confidence interval [95% CI], 12.76 to 30.20), acute coronary syndrome (aHR, 2.58; 95% CI, 1.89 to 3.52), heart failure (aHR, 3.01; 95% CI, 2.16 to 4.19), ischemic stroke (aHR, 1.80; 95% CI, 1.06 to 3.05), venous thromboembolism (aHR, 2.56; 95% CI, 1.35 to 4.85), and death (aHR, 1.34; 95% CI, 1.09 to 1.64) versus controls. Excess ESKD risk was significantly higher for FSGS and membranous nephropathy than for presumed minimal change disease. The three etiologies of primary nephrotic syndrome did not differ significantly in terms of cardiovascular outcomes and death. CONCLUSIONS: Adults with primary nephrotic syndrome experience higher adjusted rates of ESKD, cardiovascular outcomes, and death, with significant variation by underlying etiology in the risk for developing ESKD.
引用
- Go AS, Tan TC, Chertow GM, et al. Primary Nephrotic Syndrome and Risks of ESKD, Cardiovascular Events, and Death: The Kaiser Permanente Nephrotic Syndrome Study. J Am Soc Nephrol. 2021. PMID: 34362836. doi:10.1681/ASN.2020111583
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。